Introduction and objective: Polycystic ovary syndrome (PCOS) is one of the most common gynecological endocrine disorders affecting women in reproductive age. Hyperandrogenism, oligoovulation, and polycystic ovaries seen on ultrasonography are its defining features. Women affected by PCOS are...
5 March 2023 in Journal of Education, Health and Sport
Nowadays, herbal preparations are increasingly used in medicine. These preparations are cheaper, more available and they have fewer side effects than synthetic ones. Nigella Sativa, commonly known as Black Cumin, has been used in traditional medicine since antiquity. This herb is known to have many properties. The prophet Muhammad himself has already mentioned them, claiming that “Black Cumin is a cure for all diseases except death". Researches on N. Sativa confirmed that it has anti-diabetic, anti-asthmatic, pro-fertility, antioxidant, hepatoprotective, neuroprotective, gastroprotective, immunomodulatory, analgesic, antibacterial, anti-inflammatory and anti-ischemic effects. Many of these properties are due to thymoquinone, which is the main component of black cumin essential oil. This present review is an attempt to provide a specific overview of researches and literatures of pharmacognostical profile and pharmacological activity of the seeds of this plant. It will be helpful for scientists, researchers and other healthcare professionals, who are working with this plant and who need to be up to date about it.
5 February 2024 in Journal of Pre-Clinical and Clinical Research
Introduction and objective: Perinatal asphyxia (PA) is a condition of impaired blood gas exchange which, if persistent, leads to progressive hypoxemia and hypercapnia. PA is characterized by high neonatal mortality or neurodevelopmental disorders in the child’s later life. PA is closely...
3 May 2023 in Journal of Education, Health and Sport
The importance of brachial plexus palsy treatment is associated with its significant severity, along with Brachial plexus palsies can be treated by means of many different surgical and non-surgical methods which allow regeneration of full efficiency of the affected limb. The choice of method depends on such factors as type and region of injury, patient’s age or clinical presentation of the injury. The purpose of this review is to present current strategies of treating brachial plexus palsies, depending on therapeutic needs of the particular patient. This is a review study based upon selective literature overview, with emphasis on works published within past 13 years. 6 separate methods of brachial plexus palsy were assessed, without distinction of the reason of palsy occurring. Some of the invasive methods include operative treatment performed directly on occupied nervous tissue, such as microneural plexus reconstruction and nerve transfers (lower subscapular nerve transfer and contralateral C7 nerve transfer) whilst the others revolve around restoration of function of affected neighboring structures by themselves, e.g. shoulder tendon transfers. Rehabilitation and botulinum toxin-based treatment are non-operative methods revolving around enhancement of the function of the affected upper limb. Main measure of effectiveness of the treatment is assessment of the range of motion of the affected limb (ROM). There is still not enough information available regarding long-term efficiency of microneural plexus reconstruction and botulinum toxin-based treatment. They require further investigation while other methods are used commonly.
13 June 2023 in Journal of Education, Health and Sport
Primary cardiac tumors are very rare in the population. About 20% of it are malignant. The most common type of cardiac malignant tumor is angiosarcoma. This tumor has the ability to infiltrate surrounding tissues and form distant metastases. Angiosarcoma is most often located in the right atrium and it mostly attacks men. This neoplasm is difficult to diagnose, because it has no specific symptoms. Patients with this tumor may complain of a chest pain, cardiac arrhythmias, suffocation and distal oedema. The rarity of occurrence and the lack of specyfic symptoms contribute to late diagnosis of the disease and worse prognosis of patients. Angiosarcoma can also be misdiagnosed as pneumonia or more common cardiovascular disease for example coronary artery disease. In advanced stage, this tumor can even lead to myocardial rupture. Various imaging methods are used in the diagnostics of this neoplasm for example: CT, MRI, PET-CT or Echocardiography. Histopathological examinations are less frequently used due to the risk of serious complications like hemothorax. Due to the very uncommon occurrence of the angiosarcoma, guidelines describing treatment of patients with this neoplasm, have not been developed yet. Currently, surgical removal of the tumor (if it is possible), chemiotherapy and radiotherapy are used. Reaserches on the genetic mutations which cause angiosarcoma and the development of appropriate drugs may give patients a chance for more effective treatment in the future
Background: Extrachromosomal DNA (ecDNA) amplification represents a distinct mechanism of genomic instability in cancer, increasingly recognized for its role in aggressive disease progression. This review examines how ecDNA drives tumour evolution and assesses its potential as both a prognostic marker and therapeutic target. Methods: The authors integrate findings from multiple detection platforms—including FISH, whole-genome sequencing, and specialized reconstruction algorithms—and present data across diverse cancer types; no preregistration is noted, and no animal studies are included. Results: ecDNA consists of circular, acentric DNA elements carrying high-copy oncogene amplifications (such as EGFR, MYC, MDM2, and CDK4). Unlike chromosomal DNA, ecDNA segregates unevenly during cell division, generating intratumoral heterogeneity, accelerating adaptation to selective pressures, and promoting resistance to therapy. Pan-cancer surveys summarized here reveal ecDNA in a significant subset of tumours, with particularly high frequencies in liposarcoma, glioblastoma, and HER2-positive breast cancer, and consistent associations with worse clinical outcomes. Conclusions: The authors conclude that ecDNA amplification serves as a credible adverse prognostic indicator and holds promise for refining risk stratification and guiding treatment strategies. However, they stress that clinical adoption remains constrained by the absence of standardized, scalable, and reproducible detection.